Key Record Dates
| ClinicalTrials.gov Identifier: | NCT03470922 |
|---|---|
| Brief Title: | A Study of Relatlimab Plus Nivolumab Versus Nivolumab Alone in Participants With Advanced Melanoma (RELATIVITY-047) |
| First Submitted : | March 14, 2018 |
| First Submitted that Met QC Criteria : | March 14, 2018 |
| First Posted : | March 20, 2018 |
| Results First Submitted : | January 25, 2022 |
| Results First Posted with QC Comments : | February 17, 2022 |
| Results First Submitted that Met QC Criteria : | March 2, 2022 |
| Results First Posted : | March 29, 2022 |
| Last Update Submitted that Met QC Criteria : | September 15, 2023 |
| Last Update Posted : | September 21, 2023 |